Bispecific Antibody Molecule Inhibits Tumor Cell Proliferation More Efficiently Than the Two-Molecule Combination

BACKGROUND: Monoclonal antibodies (mAbs) have proved to be a valuable tool for the treatment of different cancer types. However, clinical use of an increasing number of mAbs, have also highlighted limitations with monotherapy for cancers, in particular for such with more complex mechanisms, requirin...

Descripción completa

Detalles Bibliográficos
Autores principales: Volk, Anna-Luisa, Mebrahtu, Aman, Ko, Bong-Kook, Lundqvist, Magnus, Karlander, Maximilian, Lee, Hyun-Jong, Frejd, Fredrik Y., Kim, Kyu-Tae, Lee, Jong-Seo, Rockberg, Johan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8206453/
https://www.ncbi.nlm.nih.gov/pubmed/33721246
http://dx.doi.org/10.1007/s40268-021-00339-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8206453/
https://www.ncbi.nlm.nih.gov/pubmed/33721246
http://dx.doi.org/10.1007/s40268-021-00339-2

Ejemplares similares